FDA Inspection 951971 — Vivex Biologics, Inc.

Vivex Biologics, Inc. — FEI 1000113913

The FDA completed an inspection of Vivex Biologics, Inc. on December 18, 2015 in Miami, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 18, 2015
Fiscal Year
2016
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Miami, FL (United States)

Citations

IDCFRDescription
1239821 CFR 1271.230(a)Validation & approval--established procedures